Abstract:Objective: To investigate the prognostic factors related to overall survival and prognosis of patients with simple lung metastases from primary colorectal cancer. Methods: The clinical data from 90 patients with simple lung metastases from primary colorectal cancer were retrospectively reviewed. Of these 90 patients, 34 received R0 resection of lung metastases, and 56 received systemic chemotherapy. The survival analysis was performed by Kaplan-Meier method. The log-rank test was used for univariate analysis and the COX proportional hazards model for multivariate analysis of prognosis. Results: The 1-, 2- and 3-year cumulative survival rates between the patients receiving R0 resection of lung metastases and systemic chemotherapy were significantly different (97.1% vs 82.1%, P < 0.05; 88.2% vs 55.3%, P < 0.05; 74.9% vs 31.4%, P < 0.05). The 1-, 2- and 3-year disease-free survival rates of patients receiving R0 resection of lung metastases were 64.7%, 43.9% and 33.8%, respectively. The univariate analysis revealed that in patients receiving R0 resection of lung metastases, the factors of hilar or mediastinal lymph node metastases (P = 0.003), the maximum tumor size of pulmonary metastases (P = 0.007) and preoperative serum carcinoembryonic antigen level (P = 0.029) were significantly correlated with the 3-year overall survival, and the factors of lymph node metastases after curative resection of colorectal cancer (P = 0.005), the maximum diameter of pulmonary metastases more than or equal to 4 cm (P = 0.006) and preoperative serum carcinoembryonic antigen level more than or equal to 5 ng/mL (P = 0.010) were significantly correlated with the recurrence after R0 resection of lung metastases, while in patients receiving systemic chemotherapy, the factor of use of all three cytotoxic agents including fluorouracil, oxaliplatin and irinotecan (P = 0.004) was significantly correlated with the 3-year overall survival. The mulitivariate analysis revealed that in patients receiving R0 resection of lung metastases, the factor of maximum diameter of pulmonary metastases more than or equal to 4 cm (P = 0.032) was an independent prognostic factor related to the 3-year overall survival, while the factors of positive lymph node metastases after curative resection of the primary colorectal cancer (P = 0.030) and the maximum diameter of pulmonary metastases more than or equal to 4 cm (P = 0.049) were independent prognostic factors related to the recurrence after R0 resection of lung metastases. Conclusion: The overall survival of patients receiving R0 resection of lung metastases from primary colorectal cancer especially for the patients with the maximum diameter of pulmonary metastases less than 4 cm can be significantly improved. The overall survival of patients receiving systemic chemotherapy using all three cytotoxic agents including fluorouracil, oxaliplatin and irinotecan can also be significantly prolonged. DOI:10.3781/j.issn.1000-7431.2013.02.014

Survival Benefit of Palliative Local Treatments and Efficacy of Different Pharmacotherapies in Colorectal Cancer with Lung Metastasis: Results from a Large Retrospective Study

Prognostic Factors for Colorectal Cancer Patients with Pulmonary Metastases

Longterm Effects of Palliative Local Treatment of Incurable Metastatic Lesions in Colorectal Cancer Patients

OA07.03 Addition of Local Therapy to EGFR TKI Showed Survival Benefit in EGFR-Mutant NSCLC Pts with Oligometastatic or Oligoprogressive Liver Metastases

Outcomes after Noncurative Locoregional Treatment in Patients with Unresectable Metastatic Colorectal Carcinoma.

Oncological Outcome of Unresectable Lung Metastases Without Extrapulmonary Metastases in Colorectal Cancer

Folate Receptor-Positive Circulating Tumor Cells As a Predictive Biomarker for the Efficacy of First-Line Pemetrexed-Based Chemotherapy in Patients with Non-Squamous Non-Small Cell Lung Cancer

Efficacy of Neoadjuvant Immunochemotherapy and Survival Surrogate Analysis of Neoadjuvant Treatment in IB–IIIB Lung Squamous Cell Carcinoma

Impact on survival without chemotherapy of local treatments of lung metastasis of colorectal cancers: Analysis on REPULCO cohort

Prognostic Factors Related to Simple Lung Metastases in 90 Patients with Primary Colorectal Cancer

Palliative Primary Tumor Resection Provides Survival Benefits for the Patients with Metastatic Colorectal Cancer and Low Circulating Levels of Dehydrogenase and Carcinoembryonic Antigen

Local Therapy Combined with First-Line EGFR Tyrosine Kinase Inhibitor Achieves Favorable Survival in Patients with EGFR-Mutant Metastatic Non-Small Cell Lung Cancer

Survival Investigation in Patients with Colorectal Liver Metastasis: A Single-Institution Analysis.

Long-term survival outcomes following resection of lung metastases (LM) from a colorectal primary.

Local consolidative therapy for synchronous oligometastatic non-small cell lung cancer treated with first-line pembrolizumab: A retrospective observational study

Survival benefit of local consolidative therapy for patients with single-organ metastatic pancreatic cancer: a propensity score-matched cross-sectional study based on 17 registries

Treatment of Colorectal Lung Metastases: Two Centers Retrospective Study

Outcomes of Palliative Local Treatment in Metastatic Colorectal Cancer Patients Receiving Chemotherapy Plus Bevacizumab

Survival of patients with liver metastasis from colorectal cancer by different modes of therapy: a report of 363 cases

Effect of multimodal chemotherapy on survival of gastric cancer with liver metastasis - a population based analysis

Survival Time and Prognostic Factors of Patients with Initial Noncurative Colorectal Liver Metastases